PE(16:1(9Z)/22:4(7Z,10Z,13Z,16Z))

Metabolite details

Identifier

RPHOMZKEMREJMO-FUFXABRCSA-N

InChI Key

RPHOMZKEMREJMO-FUFXABRCSA-N

IUPAC name

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropan-2-yl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate

Preferred name

PE(16:1(9Z)/22:4(7Z,10Z,13Z,16Z))

INN name

—

Synonym

—

ChEBI

CHEBI:170583

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation

Observed in differential profiles

• Wild_type_vs_hfq
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_Lithogenic_Diet
• Control_vs_Exercise